Literature DB >> 29446698

Radiological fibrosis score is strongly associated with worse survival in rheumatoid arthritis-related interstitial lung disease.

Yuhei Ito1,2, Machiko Arita1, Shogo Kumagai1, Reoto Takei1, Maki Noyama1, Fumiaki Tokioka1, Keisuke Nishimura3, Takashi Koyama4, Hiromasa Tachibana5, Tadashi Ishida1.   

Abstract

OBJECTIVES: High-resolution computed tomography (HRCT) parenchymal patterns have been used to predict prognosis in patients with interstitial lung disease (ILD). In idiopathic pulmonary fibrosis, the fibrosis score (i.e. the combined extent of reticulation and honeycombing) has been associated with worse survival. This study aimed to identify HRCT patterns and patient characteristics that can predict poor prognosis in rheumatoid arthritis-related ILD (RA-ILD).
METHODS: We retrospectively analysed 65 patients with newly diagnosed RA-ILD from 2007 to 2016 at Kurashiki Central hospital. Using univariate and bivariate Cox regression analysis, associations with mortality, were identified.
RESULTS: During a median follow-up of 56.5 months, 16/65 (24.6%) patients died. Univariate analysis identified six significant poor prognostic factors: lower baseline % predicted forced vital capacity, total interstitial disease score, reticulation score, traction bronchiectasis score, fibrosis score, and definite UIP pattern. Fibrosis score remained to be an independently significant poor prognostic factor of survival on bivariate analysis. Patients with a fibrosis score >20% had higher mortality (HR, 9.019; 95% CI, 2.87-28.35; p < .05).
CONCLUSION: This study showed that fibrosis score is strongly associated with worse survival in RA-ILD, and patients with fibrosis score >20% had a 9.019-fold increased risk of mortality.

Entities:  

Keywords:  Rheumatoid arthritis; fibrosis score; high-resolution computed tomography; interstitial lung disease; outcome measures

Mesh:

Year:  2018        PMID: 29446698     DOI: 10.1080/14397595.2018.1442170

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  9 in total

1.  Prognostic role of blood KL-6 in rheumatoid arthritis-associated interstitial lung disease.

Authors:  Ho Cheol Kim; Kwang Hun Choi; Joseph Jacob; Jin Woo Song
Journal:  PLoS One       Date:  2020-03-12       Impact factor: 3.240

Review 2.  Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review.

Authors:  Giulia Cassone; Marco Sebastiani; Caterina Vacchi; Gian Luca Erre; Carlo Salvarani; Andreina Manfredi
Journal:  Drugs Context       Date:  2021-01-15

3.  Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.

Authors:  Meihua Qiu; Jing Jiang; Jie Song; Shenchun Zou; Xueyuan Nian; Yutie Wang; Pengfei Yu
Journal:  Respir Res       Date:  2021-10-11

4.  Reticulation pattern without honeycombing on high-resolution CT is associated with the risk of disease progression in interstitial lung diseases.

Authors:  Minna Mononen; Eeva Saari; Hannele Hasala; Hannu-Pekka Kettunen; Sanna Suoranta; Hanna Nurmi; Miia Kärkkäinen; Tuomas Selander; Jukka Randell; Jari Laurikka; Toomas Uibu; Heikki Koskela; Riitta Kaarteenaho; Minna Purokivi
Journal:  BMC Pulm Med       Date:  2022-08-14       Impact factor: 3.320

5.  Safety and Effectiveness of Abatacept in a Prospective Cohort of Patients with Rheumatoid Arthritis-Associated Interstitial Lung Disease.

Authors:  Natalia Mena-Vázquez; Marta Rojas-Gimenez; Clara Fuego-Varela; Aimara García-Studer; Nair Perez-Gómez; Carmen María Romero-Barco; Francisco Javier Godoy-Navarrete; Sara Manrique-Arija; Myriam Gandía-Martínez; Jerusalem Calvo-Gutiérrez; Pilar Morales-Garrido; Coral Mouriño-Rodriguez; Patricia Castro-Pérez; Isabel Añón-Oñate; Francisco Espildora; María Carmen Aguilar-Hurtado; Ana Hidalgo Conde; Rocío Arnedo Díez de Los Ríos; Eva Cabrera César; Rocío Redondo-Rodriguez; María Luisa Velloso-Feijoo; Antonio Fernández-Nebro
Journal:  Biomedicines       Date:  2022-06-22

6.  Mortality rate in rheumatoid arthritis-related interstitial lung disease: the role of radiographic patterns.

Authors:  Maria A Nieto; Maria J Rodriguez-Nieto; Olga Sanchez-Pernaute; Fredeswinda Romero-Bueno; Leticia Leon; Cristina Vadillo; Dalifer D Freites-Nuñez; Juan A Jover; Jose L Álvarez-Sala; Lydia Abasolo
Journal:  BMC Pulm Med       Date:  2021-06-30       Impact factor: 3.317

Review 7.  Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows.

Authors:  Giulia Cassone; Andreina Manfredi; Caterina Vacchi; Fabrizio Luppi; Francesca Coppi; Carlo Salvarani; Marco Sebastiani
Journal:  J Clin Med       Date:  2020-04-10       Impact factor: 4.241

8.  The clinical efficacy of traditional Chinese medicine in the treatment of rheumatoid arthritis with interstitial lung disease: A protocol of systematic review and meta-analysis.

Authors:  Zhaoyi Liu; Jie Shen; Zhouli Shen; Dongyi He
Journal:  Medicine (Baltimore)       Date:  2020-10-09       Impact factor: 1.817

9.  [Treatment of lung fibrosis in systemic rheumatic diseases (new treatment)].

Authors:  Katharina Buschulte; Anna-Maria Hoffmann-Vold; Rucsan Dra Dobrota; Philipp Höger; Andreas Krause; Michael Kreuter
Journal:  Z Rheumatol       Date:  2021-09-10       Impact factor: 1.372

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.